igforum.bio / clive-svendsen - 185155
S
%Begin Clive Svendsen Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close 15 February 2010 01:00 AM America/Los_Angeles Clive Svendsen Director of Cedars-Sinai Regenerative Medicine Institute to Receive Prestigious ALS Research Award from American Academy of Neurology Los Angeles - Feb. 15, 2010 - Clive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis). ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease in which nerve cells called motor neurons degenerate in the brain and spinal cord.
Sebastian Silva Member
access_time 1 minutes ago
%Begin Clive Svendsen Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close 15 February 2010 01:00 AM America/Los_Angeles Clive Svendsen Director of Cedars-Sinai Regenerative Medicine Institute to Receive Prestigious ALS Research Award from American Academy of Neurology Los Angeles - Feb. 15, 2010 - Clive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis). ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease in which nerve cells called motor neurons degenerate in the brain and spinal cord.
thumb_up Like (45)
comment Reply (1)
share Share
visibility 410 views
thumb_up 45 likes
comment 1 replies
M
Madison Singh 1 minutes ago
With voluntary muscle action progressively affected, patients in the later stages of the disease may...
N
With voluntary muscle action progressively affected, patients in the later stages of the disease may become totally paralyzed. There is currently no treatment or cure that halts or reverses ALS.
Natalie Lopez Member
access_time 4 minutes ago
With voluntary muscle action progressively affected, patients in the later stages of the disease may become totally paralyzed. There is currently no treatment or cure that halts or reverses ALS.
thumb_up Like (34)
comment Reply (2)
thumb_up 34 likes
comment 2 replies
E
Evelyn Zhang 3 minutes ago
The innovative research Svendsen and his team of scientists have focused on for eight years involves...
J
Jack Thompson 2 minutes ago
The Sheila Essey Award carries a $25,000 grant to fund continued research. Additionally, Svendsen wi...
V
The innovative research Svendsen and his team of scientists have focused on for eight years involves developing specifically-engineered stem cells that, when injected into spinal cords, stalls the degeneration of nerve cells. The specialized stem cells are manufactured to release a growth factor called glial-derived neurotrophic factor (GDNF) that has been shown to support the survival of dying motor neurons.
Victoria Lopez Member
access_time 15 minutes ago
The innovative research Svendsen and his team of scientists have focused on for eight years involves developing specifically-engineered stem cells that, when injected into spinal cords, stalls the degeneration of nerve cells. The specialized stem cells are manufactured to release a growth factor called glial-derived neurotrophic factor (GDNF) that has been shown to support the survival of dying motor neurons.
thumb_up Like (26)
comment Reply (0)
thumb_up 26 likes
D
The Sheila Essey Award carries a $25,000 grant to fund continued research. Additionally, Svendsen will address the American Academy of Neurology during the group’s annual scientific meeting in Toronto on April 15.
Dylan Patel Member
access_time 8 minutes ago
The Sheila Essey Award carries a $25,000 grant to fund continued research. Additionally, Svendsen will address the American Academy of Neurology during the group’s annual scientific meeting in Toronto on April 15.
thumb_up Like (36)
comment Reply (1)
thumb_up 36 likes
comment 1 replies
S
Sofia Garcia 1 minutes ago
“First I would like to stress that the work has been a true team effort, so would like to ...
N
“First I would like to stress that the work has been a true team effort, so would like to thank my lab and collaborators over the years. I am very honored to receive the Essey Award, but constantly humbled by this tragic disease. We all know how difficult ALS is to treat and we have a long way to go,” Svendsen said.
Nathan Chen Member
access_time 15 minutes ago
“First I would like to stress that the work has been a true team effort, so would like to thank my lab and collaborators over the years. I am very honored to receive the Essey Award, but constantly humbled by this tragic disease. We all know how difficult ALS is to treat and we have a long way to go,” Svendsen said.
thumb_up Like (11)
comment Reply (2)
thumb_up 11 likes
comment 2 replies
S
Sofia Garcia 3 minutes ago
“However, this award will be used to help us continue developing novel ex vivo gene therap...
J
Jack Thompson 4 minutes ago
Prior to joining Cedars-Sinai, Svendsen served as professor and co-director of the University of Wis...
H
“However, this award will be used to help us continue developing novel ex vivo gene therapy approaches where stem cell are used as both regenerative support cells and growth factor pumps for dying motor neurons. In particular we are close to completing work on a cell bank that will allow us to move ahead to clinical trials on humans, which may provide another step forward in the treatment of ALS.” Svendsen, who recently joined the Cedars-Sinai Regenerative Medicine Institute, is a prominent stem cell scientist whose groundbreaking research focuses on both modeling and treating neurodegenerative disorders such as ALS, Huntington’s disease and Parkinson’s disease.
Henry Schmidt Member
access_time 12 minutes ago
“However, this award will be used to help us continue developing novel ex vivo gene therapy approaches where stem cell are used as both regenerative support cells and growth factor pumps for dying motor neurons. In particular we are close to completing work on a cell bank that will allow us to move ahead to clinical trials on humans, which may provide another step forward in the treatment of ALS.” Svendsen, who recently joined the Cedars-Sinai Regenerative Medicine Institute, is a prominent stem cell scientist whose groundbreaking research focuses on both modeling and treating neurodegenerative disorders such as ALS, Huntington’s disease and Parkinson’s disease.
thumb_up Like (6)
comment Reply (3)
thumb_up 6 likes
comment 3 replies
L
Liam Wilson 11 minutes ago
Prior to joining Cedars-Sinai, Svendsen served as professor and co-director of the University of Wis...
S
Scarlett Brown 2 minutes ago
The Cedars-Sinai Regenerative Medicine Institute brings together basic scientists with specialist cl...
Show 1 more replies
A
Prior to joining Cedars-Sinai, Svendsen served as professor and co-director of the University of Wisconsin Stem Cell and Regenerative Medicine Center and Director of the National Institutes of Health-funded Stem Cell Training Program. He is author of over 150 scientific publications, and senior editor of the Encyclopedia of Stem Cell Research. InDecember, Svendsen and the Cedars-Sinai Regenerative Medicine Institute received a $3.7 million National Institutes of Health grant to provide five leading laboratories with the adult stem cells to be used in the development of potential therapies to understand another fatal neurodegenerative condition Huntington’s disease.
Aria Nguyen Member
access_time 28 minutes ago
Prior to joining Cedars-Sinai, Svendsen served as professor and co-director of the University of Wisconsin Stem Cell and Regenerative Medicine Center and Director of the National Institutes of Health-funded Stem Cell Training Program. He is author of over 150 scientific publications, and senior editor of the Encyclopedia of Stem Cell Research. InDecember, Svendsen and the Cedars-Sinai Regenerative Medicine Institute received a $3.7 million National Institutes of Health grant to provide five leading laboratories with the adult stem cells to be used in the development of potential therapies to understand another fatal neurodegenerative condition Huntington’s disease.
thumb_up Like (34)
comment Reply (2)
thumb_up 34 likes
comment 2 replies
E
Elijah Patel 7 minutes ago
The Cedars-Sinai Regenerative Medicine Institute brings together basic scientists with specialist cl...
I
Isaac Schmidt 19 minutes ago
Cells produced within the Institute will be used in a variety of Cedars-Sinai Medical research progr...
M
The Cedars-Sinai Regenerative Medicine Institute brings together basic scientists with specialist clinicians, physician scientists and translational scientists across multiple medical specialties to translate fundamental stem cell studies to therapeutic regenerative medicine. The Institute is housed in new state-of-the-art laboratories designed for stem cell and regenerative medicine research. At the heart of the Institute is a specialized core facility for the production of pluripotent stem cells capable of making all tissues in the human body from adult human skin biopsies.
Madison Singh Member
access_time 32 minutes ago
The Cedars-Sinai Regenerative Medicine Institute brings together basic scientists with specialist clinicians, physician scientists and translational scientists across multiple medical specialties to translate fundamental stem cell studies to therapeutic regenerative medicine. The Institute is housed in new state-of-the-art laboratories designed for stem cell and regenerative medicine research. At the heart of the Institute is a specialized core facility for the production of pluripotent stem cells capable of making all tissues in the human body from adult human skin biopsies.
thumb_up Like (17)
comment Reply (2)
thumb_up 17 likes
comment 2 replies
T
Thomas Anderson 12 minutes ago
Cells produced within the Institute will be used in a variety of Cedars-Sinai Medical research progr...
J
Joseph Kim 20 minutes ago
29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Boost...
A
Cells produced within the Institute will be used in a variety of Cedars-Sinai Medical research programs, currently focusing on understanding the causes of and finding treatments for diseases of the brain, heart, eye, liver, kidney, pancreas and skeletal structures, as well as cancer and metabolic disorders. Share this release Clive Svendsen Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Visit our Facebook page (opens in new window) Follow us on Twitter (opens in new window) Visit our Youtube profile (opens in new window) (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept.
Ava White Moderator
access_time 18 minutes ago
Cells produced within the Institute will be used in a variety of Cedars-Sinai Medical research programs, currently focusing on understanding the causes of and finding treatments for diseases of the brain, heart, eye, liver, kidney, pancreas and skeletal structures, as well as cancer and metabolic disorders. Share this release Clive Svendsen Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Visit our Facebook page (opens in new window) Follow us on Twitter (opens in new window) Visit our Youtube profile (opens in new window) (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept.
thumb_up Like (4)
comment Reply (3)
thumb_up 4 likes
comment 3 replies
M
Madison Singh 17 minutes ago
29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Boost...
K
Kevin Wang 13 minutes ago
Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics...
Show 1 more replies
C
29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster?
Charlotte Lee Member
access_time 40 minutes ago
29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster?
thumb_up Like (2)
comment Reply (1)
thumb_up 2 likes
comment 1 replies
L
Luna Park 28 minutes ago
Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics...
J
Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home
Julia Zhang Member
access_time 11 minutes ago
Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home
thumb_up Like (17)
comment Reply (2)
thumb_up 17 likes
comment 2 replies
M
Mia Anderson 4 minutes ago
Clive Svendsen Skip to main content Close Select your preferred language English عربى 简体�...
N
Nathan Chen 8 minutes ago
With voluntary muscle action progressively affected, patients in the later stages of the disease may...

Write a Reply

Similar Discussions